Abstract Details

Title A Clinical Pharmacology Study To Determine the Selective and Non-Selective Doses of the Monoamine Oxidase Type B (MAO-B) Inhibitor, Rasagiline

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 155

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Tamar Goren, PhD (Teva Pharmaceuticals)	No disclosure on file
	No disclosure on file
	No disclosure on file
Nissim Sasson (TEVA Pharmaceuticles)	No disclosure on file
	No disclosure on file
Yoni Weiss	No disclosure on file

��ɫ��